AC Immune SA Cash Flow Statement Analysis

Operating, investing, and financing activities in millions CHF

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for AC Immune SA (ACIU) - Annual data in millions CHF
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-50.92-54.23-76.30-65.89-61.9245.44-50.95
Depreciation & Amortization2.162.221.791.901.971.690.96
Stock Based Compensation5.474.373.334.134.090.000.00
Change in Working Capital107.51-15.16-2.210.83-4.575.651.81
Change in Accounts Receivable13.55-14.800.000.00-0.030.000.00
Change in Accounts Payable0.000.77-1.07-0.082.180.000.00
Change in Other Working Capital93.961.10-0.20-6.20-2.570.000.00
Other Operating Activities1.611.103.334.130.99-0.911.45
Net Cash from Operating Activities65.84-60.41-73.57-65.69-59.5255.22-44.08
Investing Activities
Capital Expenditures-0.58-0.801.242.64-1.71-1.89-1.86
Purchases of Investments0.0066.4525.00-51.0030.000.000.00
Sales/Maturities of Investments0.000.000.000.0030.00-65.00-30.00
Other Investing Activities-104.710.000.00-0.03-0.030.00-0.18
Net Cash from Investing Activities-105.2965.6523.76-53.6628.33-66.89-32.04
Financing Activities
Debt Repayment-0.68-0.55-0.57-0.51-0.95-0.42-0.34
Common Stock Issued0.1143.800.0116.720.240.00111.53
Common Stock Repurchased0.000.00-0.010.00-0.100.000.00
Other Financing Activities-0.55-0.55-0.56-6.770.00-0.51-2.02
Net Cash from Financing Activities-1.1243.25-1.3540.75-0.8049.62109.38
Summary
Effect of Forex Changes on Cash-1.65-1.580.52-0.07-0.70-0.83-1.18
Net Change in Cash-42.2248.49-51.15-78.61-32.6937.9533.26
Cash at Beginning of Period78.4931.5982.22160.89193.59156.46124.38
Cash at End of Period36.2878.4930.6382.29160.89193.59156.46
Free Cash Flow65.27-61.21-74.81-68.32-61.2253.34-45.94
Supplemental Disclosures
Interest Paid0.130.180.480.470.350.000.00